- Daaweyn
- Markhaatiyada
- Neuroblastoma
- Buro adag
- Markhaatiyada
- TILS
- Daaweynta Unugyada NK
- Myasthenia Gravis (MG)
- Leukemia-da Lymphoblastic ee Ba'an (B-ALL)
- Lupus Erythematosus oo nidaamsan (SLE)
- Leukemia-da Lymphoblastic ee Ba'an (T-ALL)
- Lymphoma-ka aan Hodgkin ahayn (NHL)
- Myeloma badan (MM)
- Lymphom-ka Unugga B-B ee Kala-baxa
- Leukemia-da B-lymphocytic
- Myeloma
Leukemia-da Lymphoblastic ee daran (T-ALL)-03
Astaamaha Kiiska:
- Baadhista: Cudurka 'pneum T-cell lymphoblastic leukemia' ee daran
- Bilawga iyo Calaamadaha: Abriil 2020, oo lagu soo bandhigay wareer, daal, iyo dhibco dhiig ah oo maqaarka ah. Waxaa lagu ogaaday cudurka 'T-cell lymphoblastic leukemia' iyadoo la adeegsanayo baaritaanka MICM ee dhuuxa lafta.
- Daaweynta Bilowga ah: Waxaa la gaaray cafis dhammaystiran (CR) ka dib daaweynta kiimoterabiga ee VDCLP, oo ay ku xigto 2 wareeg oo kiimoterabiga ah oo la xoojiyay.
- Luulyo 19, 2020: Waxaa la siiyay tallaal unugyada asliga ah ee dhiigga oo allogeneic ah oo laga helay deeq-bixiye dumar ah (HLA 5/10 A deeq-bixiye A). Nidaamka qaboojinta waxaa ka mid ahaa shucaaca jirka oo dhan (TBI), cyclophosphamide (CY), iyo etoposide (VP-16). Unugyada asliga ah ee ku wareegsan ayaa la geliyay Luulyo 24, iyadoo soo kabashada granulocyte-ka ay ka soo kabato +10 iyo qorista platelet-ka maalinta +13. Dabagal joogto ah oo bukaan-socod ah ka dib.
- Febraayo 25, 2021: Dib u soo noqoshada dhuuxa lafta ayaa la ogaaday intii lagu jiray dabagalka.
- Daawaynta: Bilaabay daawaynta thalidomide ee afka laga qaato.
- Maarso 8: Isbitaalkayaga ayaa la dhigay.
- Qaab-dhismeedka Dhuuxa Lafaha: 61.5% qaraxyo.
- Kala soocidda Dhiigga ee Dusha sare: 15% qaraxyo.
- Tijaabinta Difaaca Jirka: 35.25% unugyo muujinaya CD99, CD5, CD3dim, CD8dim, CD7, cCD3, CD2dim, HLA-ABC, cbcl-2, CD81, CD38, oo muujinaya unugyada T ee aan qaan gaarin ee halista ah.
- Falanqaynta Kroomosmka: 46, XX [9].
- Hiddo-sidayaasha Isku-dhafka Leukemia: Hiddo-sidayaasha isku-dhafka SIL-TAL1 ee togan; cabbirka tirada: SIL-TA.
- Isbeddelka Burada Dhiigga: Taban.
- Falanqaynta Chimerism (ka dib HSCT): Unugyada ka soo jeeda deeq-bixiyayaashu waxay ahaayeen 45.78%.
- Maarso 11: Ururinta unugyada dhiigga ee isku-dhafan ee iswada si loogu sameeyo unugyada CD7-CART.
- Daawaynta: VILP (VDS 4mg, IDA 10mg, L-asparaginase 10,000 IU qd x 4 maalmood, Dex 9mg q12h x 9 maalmood) oo lagu daray thalidomide si loo xakameeyo burooyinka.
- Maarso 19: Kiimikada daaweynta FC (Hargabka 50mg x 3 maalmood, CTX 0.4gx 3 maalmood).
- Maarso 24 (kahor gelinta): Qaab-dhismeedka dhuuxa lafta ayaa muujiyay heerka V hyperplasia, iyadoo 22% qaraxyo ay dhaceen.
- Cytometry Socodka Dhuuxa Lafaha: 29.21% unugyo (unugyada nuclear-ka) oo muujiya CD3, CD5, CD7, CD99, oo qayb ahaan muujiya cCD3, taasoo muujinaysa unugyada T ee aan qaan-gaarin ee halista ah.
- Hiddo-sidayaasha Isku-dhafka SIL-TAL1 ee tirada leh: 1.913%.
sharraxaad2
Submit An Free Inquiry
Our medical team will make an evaluation for you, based on the information you provided. This procedure is free of charge.

